Table of Contents Author Guidelines Submit a Manuscript
Journal of Pharmaceutics
Volume 2016, Article ID 8471520, 12 pages
http://dx.doi.org/10.1155/2016/8471520
Research Article

Cellulose Acetate 398-10 Asymmetric Membrane Capsules for Osmotically Regulated Delivery of Acyclovir

Department of Pharmaceutics, Rajiv Academy for Pharmacy, Mathura, Uttar Pradesh 281001, India

Received 26 October 2015; Revised 4 January 2016; Accepted 13 January 2016

Academic Editor: Giuseppina De Simone

Copyright © 2016 Alka Sonkar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. M. Herbig, J. R. Cardinal, R. W. Korsmeyer, and K. L. Smith, “Asymmetric-membrane tablet coatings for osmotic drug delivery,” Journal of Controlled Release, vol. 35, no. 2-3, pp. 127–136, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. C.-Y. Wang, H.-O. Ho, L.-H. Lin, Y.-K. Lin, and M.-T. Sheu, “Asymmetric membrane capsules for delivery of poorly water-soluble drugs by osmotic effects,” International Journal of Pharmaceutics, vol. 297, no. 1-2, pp. 89–97, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. A. G. Thombre, A. R. DeNoto, and D. C. Gibbes, “Delivery of glipizide from asymmetric membrane capsules using encapsulated excipients,” Journal of Controlled Release, vol. 60, no. 2-3, pp. 333–341, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. M. S. Chauhan, A. Kumar, and K. Pathak, “Osmotically regulated floating asymmetric membrane capsule for controlled site-specific delivery of ranitidine hydrochloride: optimization by central composite design,” AAPS PharmSciTech, vol. 13, no. 4, pp. 1492–1501, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. P. K. Choudhury, M. S. Ranawat, M. K. Pillai, and C. S. Chauhan, “Asymmetric membrane capsule for osmotic delivery of flurbiprofen,” Acta Pharmaceutica, vol. 57, no. 3, pp. 343–350, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Garg, M. Gupta, and H. N. Bhargava, “Effect of formulation parameters on the release characteristics of propranolol from asymmetric membrane coated tablets,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 67, no. 3, pp. 725–731, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. K. C. Waterman, G. S. Goeken, S. Konagurthu et al., “Osmotic capsules: a universal oral, controlled-release drug delivery dosage form,” Journal of Controlled Release, vol. 152, no. 2, pp. 264–269, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Dhaliwal, S. Jain, H. P. Singh, and A. K. Tiwary, “Osmotic capsules: a universal oral, controlled-release drug delivery dosage form,” The AAPS Journal, vol. 10, pp. 322–330, 2008. View at Google Scholar
  9. A. Kristl, S. Srčič, F. Vrečer, B. Šuštar, and D. Vojnovic, “Polymorphism and pseudopolymorphism: influencing the dissolution properties of the guanine derivative acyclovir,” International Journal of Pharmaceutics, vol. 139, no. 1-2, pp. 231–235, 1996. View at Publisher · View at Google Scholar
  10. AHFS Drug Information, American Society of Hospital Pharmacists, Bethesda, Md, USA, 2004.
  11. C. Fletcher and B. Bean, “Evaluation of oral acyclovir therapy,” Drug Intelligence and Clinical Pharmacy, vol. 19, no. 7-8, pp. 518–524, 1985. View at Google Scholar · View at Scopus
  12. E. A. Rawlins, Bentley's Textbook of Pharmaceutics, Bailliere Tindall, London, UK, 2004.
  13. S. Bolton, Pharmaceutical Statistics: Practical and Clinical Application, Marcel Dekker, New York, NY, USA, 1990.
  14. R. Dev, A. Kumar, and K. Pathak, “Solubility-modulated asymmetric membrane tablets of triprolidine hydrochloride: statistical optimization and evaluation,” AAPS PharmSciTech, vol. 13, no. 1, pp. 174–183, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. Indian Pharmacopoeia, Government of India, Ministry of Health & Family Welfare, vol. 2, Controller of Publication, New Delhi, India, 2007.
  16. Stability Testing of New Drug Substances and Products Q1A-Q1F, December 2014, http://www.ich.org/products/guidelines/quality/quality-single/article/stability-testing-of-new-drug-substances-and-products.html.
  17. A. Kristl, “Estimation of aqueous solubility for some guanine derivatives using partition coefficient and melting temperature,” Journal of Pharmaceutical Sciences, vol. 88, no. 1, pp. 109–110, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Luengo, T. Aránguiz, J. Sepúlveda, L. Hernández, and C. Von Plessing, “Preliminary pharmacokinetic study of different preparations of acyclovir with β-cyclodextrin,” Journal of Pharmaceutical Sciences, vol. 91, no. 12, pp. 2593–2598, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Kumar, A. K. Philip, and K. Pathak, “Asymmetric membrane capsules of phenylephrine hydrochloride: an osmotically controlled drug delivery system,” Current Drug Delivery, vol. 8, no. 5, pp. 474–482, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. R. A. Keraliya, C. Patel, P. Patel et al., “Osmotic drug delivery system as a part of modified release dosage form,” ISRN Pharmaceutics, vol. 2012, Article ID 528079, 9 pages, 2012. View at Publisher · View at Google Scholar
  21. S. Budavari, The Merck Index: An Encyclopedia of Chemicals, Drugs and Biological, Merck Research Laboratories, Division of Merck and Co, 12th edition, 1996.
  22. L. Liu, G. Khang, J. M. Rhee, and H. B. Lee, “Preparation and characterization of cellulose acetate membrane for monolithic osmotic tablet,” Korea Polymer Journal, vol. 7, no. 5, pp. 289–297, 1999. View at Google Scholar · View at Scopus
  23. A. K. Philip and K. Pathak, “Osmotic flow through asymmetric membrane: a means for controlled delivery of drugs with varying solubility,” AAPS PharmSciTech, vol. 7, no. 3, article 56, 2006. View at Google Scholar
  24. A. K. Philip and K. Pathak, “In situ-formed asymmetric membrane capsule for osmotic release of poorly water-soluble drug,” PDA Journal of Pharmaceutical Science and Technology, vol. 61, no. 1, pp. 24–36, 2007. View at Google Scholar
  25. A. K. Philip, K. Pathak, and P. Shakya, “Asymmetric membrane in membrane capsules: a means for achieving delayed and osmotic flow of cefadroxil,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 69, no. 2, pp. 658–666, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. S. N. Makhija and P. R. Vavia, “Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine: I. Cellulose acetate as a semipermeable membrane,” Journal of Controlled Release, vol. 89, no. 1, pp. 5–18, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. R. C. Rowe, P. J. Shesky, and S. C. Owens, Handbook of Pharmaceutical Excipients, Pharmaceutical Press, London, UK, 5th edition, 2006.
  28. M. K. Shah and K. Pathak, “Development and statistical optimization of solid lipid nanoparticles of simvastatin by using 23 full-factorial design,” AAPS PharmSciTech, vol. 11, no. 2, pp. 489–496, 2010. View at Publisher · View at Google Scholar
  29. United States Pharmacopoeia, Asian Edition, US Pharmacopeial Convention, Rockville, Md, USA, 2004.
  30. L. W. Donald, Handbook of Pharmaceutical Controlled Release Technology, Marcel Dekker, New York, NY, USA, 2000.